Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

beta-2 Microglobulin antibody

This anti-beta-2 Microglobulin antibody is a Mouse Monoclonal antibody detecting beta-2 Microglobulin in WB, FACS, IF and IHC (f). Suitable for Human.
Catalog No. ABIN6936448

Quick Overview for beta-2 Microglobulin antibody (ABIN6936448)

Target

See all beta-2 Microglobulin (B2M) Antibodies
beta-2 Microglobulin (B2M) (beta-2-Microglobulin (B2M))

Reactivity

  • 241
  • 55
  • 49
  • 33
  • 11
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Host

  • 149
  • 130
  • 9
  • 6
  • 2
  • 1
Mouse

Clonality

  • 163
  • 133
  • 1
Monoclonal

Conjugate

  • 134
  • 35
  • 26
  • 14
  • 13
  • 7
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This beta-2 Microglobulin antibody is un-conjugated

Application

  • 166
  • 136
  • 101
  • 88
  • 79
  • 53
  • 47
  • 39
  • 26
  • 21
  • 17
  • 17
  • 14
  • 13
  • 11
  • 6
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Flow Cytometry (FACS), Immunofluorescence (IF), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))

Clone

B2M-1118
  • Specificity

    Beta2 microglobulin is a 12KDa protein with a pI of 5.6. Serum beta2 microglobulin levels are a reflection of cell turnover. Levels rise with fever, inflammation, and infection. Increased serum levels are also seen in B-cell malignancies and in renal failure and may indicate a worse prognosis for patients with early-stage Hodgkin's lymphoma. In urine, increased levels are seen in proximal renal tubular disease as well as renal transplant rejection. Beta2 microglobulin levels can rise either because its rate of synthesis has increased (e.g. in AIDS, malignant monoclonal plasma cell dyscrasia, solid tumours and autoimmune disease) or because of impaired renal filtration (e.g. due to renal insufficiency, graft rejection or nephrotoxicity induced by post-transplantation immunosuppressive therapy).

    Cross-Reactivity (Details)

    Human. Non-Human primates.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Full length recombinant human B2M protein

    Isotype

    IgG1 kappa
  • Application Notes

    Known_Application: Flow Cytometry (1-2 μg/million cells), Western Blot (1-2 μg/mL),Immunofluorescence (1-2 μg/mL), Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT) (Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes), Optimal dilution for a specific application should be determined.

    Positive_Control: HL-60 or HeLa cells. Melanomas and Lymphoma. Carcinoma of Stomach, Cervix, Endometrial, Kidney or Colon.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Preservative

    Azide free

    Storage

    -20 °C,-80 °C

    Storage Comment

    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Expiry Date

    24 months
  • Target

    beta-2 Microglobulin (B2M) (beta-2-Microglobulin (B2M))

    Alternative Name

    B2M

    Background

    B2M, Beta 2 microglobin, Beta 2 microglobulin, Beta chain of MHC class I molecules, Beta-2-microglobulin form pI 5.3, Hdcma22p,Beta-2 Microglobulin (Renal Failure & Tumor Marker)
    Cellular localisation: Cell Surface and Extracellular (Secreted)

    Molecular Weight

    12kDa

    Gene ID

    567, 534255

    UniProt

    P61769

    Pathways

    TCR Signaling, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
You are here:
Chat with us!